Zachary Parker, Cre
About Zachary Parker, Cre
Zachary Parker serves as the President and CEO of DLH Corporation, a position he has held since 2010. He possesses extensive experience in technology and research operations, with a strong focus on strategic planning and innovation across various sectors.
Work at DLH Corporation
Zachary Parker has served as President & CEO of DLH Corporation since 2010. Under his leadership, the company has focused on providing technology and research-based operations for various clients, including federal agencies. He has also been a member of the Board of Directors at DLH Corporation since the same year, contributing to strategic decision-making and governance.
Previous Experience
Prior to his role at DLH Corporation, Zachary Parker worked at Northrop Grumman Mission Systems & IT as Executive Director from 1989 to 2008, accumulating 19 years of experience in the field. He also held the position of Manager, Systems Engineering at VSE Corporation from 1980 to 1983, gaining foundational experience in systems engineering.
Education and Expertise
Zachary Parker has an extensive educational background, including studies at The Wharton School, where he achieved certification in Executive Financial Management. He also studied Reliability Engineering at UCLA and earned certifications in Earned Value Management from the University of Virginia Darden School of Business. His expertise spans cyber information security, statistical data analytics, and digital transformation.
Leadership Roles
In addition to his role at DLH Corporation, Zachary Parker has been a member of the Board of Directors for the Professional Services Council since 2019. He is also involved with Leadership Atlanta as a member of the Class of 2016. His leadership roles demonstrate his commitment to advancing the professional services sector and community engagement.
Specializations and Initiatives
Zachary Parker specializes in strategic planning and innovation, particularly in mergers and acquisitions. He has been involved in initiatives related to anti-terrorism force protection and emergency preparedness. His background includes a strong focus on public health, surveillance, and clinical trials, addressing both chronic and infectious diseases.